# A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent

> **NCT01252914** · PHASE4 · COMPLETED · sponsor: **Glaukos Corporation** · enrollment: 80 (estimated)

## Conditions studied

- Subject With Primary Open-angle Glaucoma (POAG)

## Interventions

- **DEVICE:** iStent Supra Stent

## Key facts

- **NCT ID:** NCT01252914
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2019-12-16
- **Final completion:** 2019-12-16
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01252914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01252914, "A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01252914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*